Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002155
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Six-Month Safety and Antiviral Study in HIV-1 Seropositive AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cellsmm3 to Evaluate MK-639 Alone Versus Zidovudine AZT and 3TC Versus the Combination of MK-639 With AZT3TC
Sponsor:
Merck Sharp Dohme LLC
Organization:
NIH AIDS Clinical Trials Information Service